Basically, he?s saying, get used to it. Pfizer is preparing for the loss of its patent protection on the world?s top-selling drug, Lipitor. The ...
... are still unsure whther the firm has the means to deal with the patent loss it will face on the cholesterol blockbuster Lipitor (atorvastatin) in 2010. ...
... structure would prepare it for the impending expiry of the patent for its blockbuster cholesterol drug Lipitor, worth some $12bn in annual sales. ...
You might have seen him on TV throughout the past couple of years touting the healing power of Lipitor, a cholesterol drug made by Pfizer. ...
... structure would prepare it for the impending expiry of the patent for its blockbuster cholesterol drug Lipitor, worth some $12bn in annual sales. ...
In Lipitor ads, I said that people with several risk factors should ask their doctors about it. I am a medical doctor, I am widely known as an artificial ...
Pfizer Inc.'s Lipitor campaign featuring Robert Jarvik came under scrutiny by Congress as part of an investigation of celebrity endorsements of prescription ...
The decision has no commercial impact because Pfizer's basic patent covering Lipitor (EP 247633) remains in force and expires in November 2011. ...
Press Photo/Lance WynnCaught in a crunch: Doug Olson, of Ada, holds samples of Lipitor, the anti-cholesterol drug his doctor prescribed to help prevent a ...
... which has a lean drug pipeline and could see generic competition as early as 2010 for its biggest product, the cholesterol drug Lipitor. ...